Potential value of expression of receptor accessory protein 4 for evaluating the prognosis of lower-grade glioma patients
CONCLUSIONS: In brief, this study is the first to introduce REEP4 in malignant tumors, which can be used as an independent risk factor that participates in the malignant process of LGG. More importantly, REEP4 has the potential to become a new star in the field of anti-tumor treatment.PMID:38552216 | DOI:10.18632/aging.205695
Source: Aging - Category: Biomedical Science Authors: Shuping Luo Zhendong Liu Haigang Chang Xingbo Cheng Rongjun Qian Yanzheng Gao Chaofeng Hou Source Type: research
More News: Biology | Biomedical Science | Brain Tumor | Cancer | Cancer & Oncology | Glioma | Molecular Biology | Study